A physician with nearly two decades of experience in the medical field, Dr. Erol Onel leads teams responsible for acquiring approval for non-opioid drugs as the vice president of Heron Therapeutics in La Jolla, California. Dr. Erol Onel also belongs to the American Society of Andrology (ASA), which will host its 43rd Annual Conference in the spring of 2018.
The ASA Annual Conference unites scientists and clinicians from across the globe to explore new information about the male reproductive system. Using a multidisciplinary approach, the conference will host a plethora of workshops, sessions, and presentations that fit the theme of Andrology Today, Tomorrow, and Beyond – Bridging Science and Clinical Practice. Workshops will feature hands-on interaction and opportunities for scientists and clinicians to advance their knowledge. Additionally, the conference will present the clinical symposium TRANSformations: Andrology and Transgender Medicine. Attendees may also participate in a range of networking activities.
Conference registration fees cover entrance to scientific sessions, program materials, continental breakfasts and breaks, and one ticket to the Welcome Reception. Early registration is available until March 20, 2018. The conference will take place at The Nines Portland in Oregon on April 21-24, 2018.